tetradecanoylphorbol acetate has been researched along with rosiglitazone in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 17 (80.95) | 29.6817 |
2010's | 3 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burris, TP; Demarest, KT; Pelton, PD; Zhou, L | 1 |
Kitahara, M; Naitoh, T; Tsuruzoe, N | 1 |
Chandraratna, RA; Fleck, E; Goetze, S; Graf, K; Hsueh, WA; Kim, S; Kintscher, U; Law, RE; Nagpal, S; Wakino, S | 1 |
Brüne, B; Von Knethen A, A | 1 |
Bond, R; Cook, J; Gilkeson, G; Guyton, K; Halushka, P; Reilly, C | 1 |
Bierhaus, A; Brodbeck, K; Häring, HU; Schleicher, ED; Weigert, C | 1 |
Biswas, S; Dallas-Yang, Q; Jiang, G; Li, Z; Zhang, BB | 1 |
Alemany, S; Caivano, M; Cohen, P; Rodriguez, C | 1 |
Benéteau, N; Chapuis, V; Colpaert, FC; Dupont-Passelaigue, E; Junquéro, D; Lestienne, F; Patoiseau, JF; Rival, Y; Taillandier, T | 1 |
Alegret, M; Ciudad, CJ; Laguna, JC; Llaverias, G; Noé, V; Sánchez, RM; Vázquez-Carrera, M | 1 |
Hirakata, M; Imura, Y; Sugiyama, Y; Tozawa, R | 1 |
Bell, D; McDermott, BJ | 1 |
Fischer, SM; He, G; Lubet, RA; Muga, S; Thuillier, P | 1 |
Evans, LM; Lazarus, JH; Okosieme, OE; Parkes, AB; Premawardhana, LD; Thomas, AW | 1 |
Burgermeister, E; Chuderland, D; Hanoch, T; Liscovitch, M; Meyer, M; Seger, R | 1 |
Combs, CK; Woster, AP | 1 |
Chen, DZ; Guo, J; Niu, XL; Pei, JM; Wang, WQ; Zhou, XD; Zhu, MZ; Zhu, XL; Zhu, XX | 1 |
Gidlund, M; Jancar, S; Ketelhuth, DF; Melo, IB; Rios, FJ | 1 |
Carluccio, MA; De Caterina, R; Distante, A; Massaro, M; Scoditti, E; Storelli, C | 1 |
Batthyany, CI; Bonacci, G; Freeman, BA; Kelley, EE; Khoo, NK; Rudolph, TK; Rudolph, V; Schopfer, FJ | 1 |
Beguinot, F; Ciccarelli, M; Formisano, P; Longo, M; Miele, C; Mirra, P; Nigro, C; Oriente, F; Perruolo, G; Spinelli, R; Ungaro, P; Vastolo, V | 1 |
21 other study(ies) available for tetradecanoylphorbol acetate and rosiglitazone
Article | Year |
---|---|
PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes.
Topics: Adipocytes; Carrier Proteins; Cell Differentiation; Cell Line; Cells, Cultured; Chromans; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Gene Expression; Humans; Kinetics; Monocytes; Myelin P2 Protein; Neoplasm Proteins; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Suppressor Proteins | 1999 |
The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
Topics: Antineoplastic Agents; Carcinogens; Cell Survival; Cells, Cultured; Chromans; Humans; Hypoglycemic Agents; Ligands; Monocytes; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Necrosis Factor-alpha | 2000 |
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Cell Movement; Chemokine CCL2; Chemotaxis; Chromans; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinases; Monocytes; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2000 |
Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages.
Topics: Animals; Cell Line; Cell Survival; Cells, Cultured; Escherichia coli; Genes, Reporter; Humans; Hypoglycemic Agents; Interferon-gamma; Lipopolysaccharides; Luciferases; Macrophages; Mice; Microbodies; Monocytes; NG-Nitroarginine Methyl Ester; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Respiratory Burst; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection | 2001 |
Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
Topics: Animals; Cyclopentanes; DNA-Binding Proteins; Enzyme Activation; Epoprostenol; I-kappa B Proteins; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-KappaB Inhibitor alpha; Nitric Oxide; Phosphorylation; Prostaglandin D2; Protein Processing, Post-Translational; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Thromboxane B2; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |
c-Fos-driven transcriptional activation of transforming growth factor beta-1: inhibition of high glucose-induced promoter activity by thiazolidinediones.
Topics: Animals; Cells, Cultured; Chromans; Glucose; Hydrogen Peroxide; Mice; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Swine; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1; Troglitazone | 2003 |
Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
Topics: Adipocytes; Adipose Tissue; Animals; Cell Line; Drug Synergism; Fatty Acids; Humans; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Mitogen-Activated Protein Kinases; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Serine; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transcription Factors | 2004 |
15-Deoxy-Delta12,14-prostaglandin J2 regulates endogenous Cot MAPK kinase kinase 1 activity induced by lipopolysaccharide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinogens; Cell Division; Cell Line; Enzyme Activation; Enzyme Inhibitors; Fibrinolytic Agents; Gene Expression Regulation, Enzymologic; Indoles; Ligands; Lipopolysaccharides; Macrophages; Maleimides; MAP Kinase Kinase Kinases; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Precipitin Tests; Prostaglandin D2; Protein Isoforms; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; RNA, Messenger; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Time Factors | 2003 |
Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.
Topics: Acetamides; Acetates; Anilides; Cardiovascular Agents; Cell Line; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fenofibrate; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins, LDL; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mevalonic Acid; Monocytes; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tetradecanoylphorbol Acetate; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Transcription Factors | 2004 |
Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.
Topics: Anilides; Animals; Apoptosis; Base Sequence; Binding Sites; Blotting, Western; Caspase 3; Caspases; Caveolin 1; Caveolins; CD11b Antigen; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Hydroxycholesterols; Ligands; Liver X Receptors; Macrophages; Molecular Sequence Data; Orphan Nuclear Receptors; PPAR gamma; Promoter Regions, Genetic; Protein Biosynthesis; Rats; Receptors, Cytoplasmic and Nuclear; RNA; RNA, Messenger; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Time Factors; Transcription, Genetic; Up-Regulation; Vasodilator Agents | 2004 |
Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation.
Topics: Cell Differentiation; Cell Line; Cholesterol; Dose-Response Relationship, Drug; Foam Cells; Homeostasis; Humans; Hypoglycemic Agents; Macrophages; Pioglitazone; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones | 2004 |
Effects of rosiglitazone and interactions with growth-regulating factors in ventricular cell hypertrophy.
Topics: Animals; Cell Survival; Cells, Cultured; Culture Media; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Interactions; Endothelin-1; Glucose; Heart Ventricles; Hypertrophy; Insulin; Insulin-Like Growth Factor I; Isoproterenol; Male; Myocytes, Cardiac; Norepinephrine; Phenylalanine; Rats; Rats, Sprague-Dawley; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones | 2005 |
The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Chromans; Diet; Female; Keratinocytes; Ligands; Mice; PPAR gamma; RNA, Messenger; Rosiglitazone; Skin Neoplasms; Tetradecanoylphorbol Acetate; Thiazolidinediones; Troglitazone; Ultraviolet Rays | 2005 |
Peripheral cytokine expression in autoimmune thyroiditis: effects of in vitro modulation by rosiglitazone and dexamethasone.
Topics: Adult; Aged; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Dexamethasone; Female; Gene Expression Regulation; Glucocorticoids; Hashimoto Disease; Humans; Hypoglycemic Agents; Interferon-gamma; Interleukin-4; Male; Middle Aged; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Thyroiditis, Autoimmune | 2006 |
Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.
Topics: Active Transport, Cell Nucleus; Acyl-CoA Oxidase; Animals; Cell Nucleus; Chlorocebus aethiops; CHO Cells; COS Cells; Cricetinae; Cricetulus; Cytosol; Down-Regulation; HeLa Cells; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 3; PPAR gamma; Protein Binding; Protein Structure, Tertiary; Protein Transport; Rats; Rosiglitazone; Serine; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transcriptional Activation; Two-Hybrid System Techniques | 2007 |
Differential ability of a thiazolidinedione PPARgamma agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Cytokines; Humans; I-kappa B Proteins; Ligands; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Microglia; Monocytes; NF-KappaB Inhibitor alpha; PPAR gamma; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones | 2007 |
[Inhibitory effects of rosiglitazone against endothelin-1-induced proliferation of rat cardiac myocytes: the role of PKC-c-fos pathway].
Topics: Animals; Animals, Newborn; Blotting, Western; Cell Enlargement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin-1; Hypoglycemic Agents; Myocytes, Cardiac; Protein Kinase C; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Tetradecanoylphorbol Acetate; Thiazolidinediones | 2008 |
Role of PPAR-gamma in the modulation of CD36 and FcgammaRII induced by LDL with low and high degrees of oxidation during the differentiation of the monocytic THP-1 cell line.
Topics: Anilides; CD11b Antigen; CD18 Antigens; CD36 Antigens; Cell Differentiation; Cell Line; Chromatography, Ion Exchange; Fatty Acids, Unsaturated; Humans; Lipoproteins, LDL; Monocytes; Oxidation-Reduction; PPAR gamma; Receptors, IgG; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Thiobarbituric Acid Reactive Substances | 2008 |
PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Topics: Angiogenesis Inhibitors; Anilides; Benzhydryl Compounds; Benzophenones; Binding Sites; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; Endothelial Cells; Epoxy Compounds; Gene Expression Regulation, Enzymologic; Humans; Neovascularization, Physiologic; Nitrobenzenes; PPAR gamma; Promoter Regions, Genetic; Protein Kinase C-alpha; Protein Transport; RNA Interference; RNA, Messenger; Rosiglitazone; Sulfonamides; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transfection; Tyrosine; Vascular Endothelial Growth Factor A | 2010 |
Electrophilic fatty acids regulate matrix metalloproteinase activity and expression.
Topics: Animals; Carcinogens; Cell Line; Enzyme Activation; Enzyme Precursors; Gene Expression Regulation, Enzymologic; Humans; Hypoglycemic Agents; Inflammation; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Knockout; Oleic Acids; PPAR gamma; Protein Structure, Tertiary; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transcription, Genetic | 2011 |
Peroxisome proliferator-activated receptor-γ activation enhances insulin-stimulated glucose disposal by reducing ped/pea-15 gene expression in skeletal muscle cells: evidence for involvement of activator protein-1.
Topics: Animals; Apoptosis Regulatory Proteins; Diet, High-Fat; Feeding Behavior; Gene Expression Regulation; Gene Silencing; Glucose; HeLa Cells; Humans; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Cells; Muscle, Skeletal; Phosphoproteins; PPAR gamma; Promoter Regions, Genetic; Protein Binding; Rats; Rosiglitazone; Signal Transduction; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transcription Factor AP-1; Transcription, Genetic | 2012 |